159
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Modelling the economic and health consequences of cardiac resynchronization therapy in the UK

, , , , &
Pages 1171-1179 | Accepted 24 Apr 2006, Published online: 15 May 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Usame Yakutcan, Eren Demir, John R. Hurst & Paul C. Taylor. (2022) Patient pathway modelling using discrete event simulation to improve the management of COPD. Journal of the Operational Research Society 73:4, pages 754-778.
Read now

Articles from other publishers (16)

Bożena Mielczarek & Jacek Zabawa. 2018. Simulation and Modeling Methodologies, Technologies and Applications. Simulation and Modeling Methodologies, Technologies and Applications 241 260 .
Jill L Colquitt, Diana Mendes, Andrew J Clegg, Petra Harris, Keith Cooper, Joanna Picot & Jackie Bryant. (2014) Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation. Health Technology Assessment 18:56, pages 1-560.
Crossref
Jonathan Karnon & Hossein Haji Ali Afzali. (2014) When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES. PharmacoEconomics 32:6, pages 547-558.
Crossref
Bożena Mielczarek. (2014) Simulation modelling for contracting hospital emergency services at the regional level. European Journal of Operational Research 235:1, pages 287-299.
Crossref
Timothy A Fairbairn, David M Meads, Claire Hulme, Adam N Mather, Sven Plein, Daniel J Blackman & John P Greenwood. (2013) The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart 99:13, pages 914-920.
Crossref
Boris Sobolev, Victor Sanchez & Lisa KuramotoBoris Sobolev, Victor Sanchez & Lisa Kuramoto. 2012. Health Care Evaluation Using Computer Simulation. Health Care Evaluation Using Computer Simulation 53 62 .
Alexander Goehler, Benjamin P. Geisler, Jennifer M. Manne, Beate Jahn, Annette Conrads-Frank, Petra Schnell-Inderst, G. Scott Gazelle & Uwe Siebert. (2011) Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure. PharmacoEconomics 29:9, pages 753-769.
Crossref
G. Boriani, L. G. Mantovani, M. Biffi, M. J. Schalij, C. Martignani, C. Leclercq, J. J. Bax & A. Auricchio. (2011) Cardiac resynchronization therapy: a cost or an investment?. Europace 13:suppl 2, pages ii32-ii38.
Crossref
Michael L. Bernard & Michael R. Gold. (2011) Economic Implications and Cost-effectiveness of Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy. Heart Failure Clinics 7:2, pages 241-250.
Crossref
Daniel Callejo, Mercedes Guerra, Antonio Hernández-Madrid & Juan A. Blasco. (2010) Evaluación económica de la terapia de resincronización cardiaca. Revista Española de Cardiología 63:11, pages 1235-1243.
Crossref
Navonil Mustafee, Korina Katsaliaki & Simon J.E. Taylor. (2010) Profiling Literature in Healthcare Simulation. SIMULATION 86:8-9, pages 543-558.
Crossref
Daniel Callejo, Mercedes Guerra, Antonio Hern?ndez-Madrid & Juan A. Blasco. (2010) Economic Assessment of Cardiac Resynchronization Therapy. Revista Espa?ola de Cardiolog?a (English Edition) 63:11, pages 1235-1243.
Crossref
G. Boriani, M. Biffi, C. Martignani, C. Valzania, I. Diemberger, M. Bertini, G. Domenichini, M. Ziacchi & A. Branzi. (2009) Is cardiac resynchronization therapy cost-effective?. Europace 11:Supplement 5, pages v93-v97.
Crossref
Mary Bond, Stuart Mealing, Rob Anderson, John Dean, Ken Stein & Rod S. Taylor. (2009) Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction?. International Journal of Cardiology 137:3, pages 206-215.
Crossref
Shien Guo, Duygu Bozkaya, Alexandra Ward, Judith A. OʼBrien, Khajak Ishak, Randy Bennett, Ahmad Al-Sabbagh & Dennis M. Meletiche. (2009) Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a. PharmacoEconomics 27:1, pages 39-53.
Crossref
Huseyin Baris Deniz, J Jaime Caro, Alexandra Ward, Jorgen Moller & Farzana Malik. (2008) Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy. Journal of Cardiovascular Medicine 9:1, pages 43-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.